L01XX32 - Результати пошуку

Саудівська Аравія - англійська - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

bortada solution for injection

stada arzneimittel gmbh, germany - bortezomib - solution for injection - 2.5 mg

Саудівська Аравія - англійська - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

veltero solution for injection

saudi amarox, saudi arabia - bortezomib - solution for injection - 3.5 mg

Ірландія - англійська - HPRA (Health Products Regulatory Authority)

bortezomib 3.5 mg powder for solution for injection

msn labs europe limited - bortezomib - powder for solution for injection - bortezomib

Ірландія - англійська - HPRA (Health Products Regulatory Authority)

bortezomib 3.5 mg powder for solution for injection

baxter holding b.v. - bortezomib - powder for solution for injection - bortezomib

Ізраїль - англійська - Ministry of Health

bortezomib fresenius kabi 3.5 mg

neopharm (israel) 1996 ltd - bortezomib - powder for solution for injection - bortezomib 3.5 mg/vial - bortezomib - multiple myelomabortezomib fresenius kabi is indicated for the treatment of adult patients with multiple myeloma.mantle cell lymphomabortezomib fresenius kabi for injection is indicated for the treatment of patients with mantle cell lymphoma who have received at least one prior therapy. bortezomib fresenius kabi in combination with rituximab, cyclophosphamide, doxorubicin and prednisone is indicated for the treatment of adult patients with previously untreated mantle cell lymphoma who are unsuitable for haematopoietic stem cell transplantation.

Ірландія - англійська - HPRA (Health Products Regulatory Authority)

bortezomib 3.5 mg powder for solution for injection

reddy holding gmbh - bortezomib - powder for solution for injection - bortezomib